DOES OBSESSION OF IRRATIONAL STACKING ANABOLIC STEROIDS WITH TRENBOLONE ACETATE OVER DECADES LEADS TO GENERAL, CARDIOVASCULAR OR SOCIAL DEVIATION PROBLEM IN YOUNG ADULTS, OR JUST BIGGEST MUSCLE MASS IS EQUAL HIGHEST SOCIAL REPUTATION IN GYM AND IS THIS ALL PRICE HEALTH WORTH? - CASE REPORT

Authors

  • Sid Solaković Cardiovascular Surgery Clinic University of Sarajevo, Clinic Vascular and Endovascular Surgery Department, Bosnia and Herzegovina
  • Mensur Vrcić Faculty of Sport and Physical Education, University of Sarajevo, Bosnia and Herzegovina
  • Ratko Pavlović Faculty Physical Education and Sport, University of East Sarajevo, Bosnia and Herzegovina

DOI:

https://doi.org/10.46827/ejpe.v0i0.2355

Keywords:

anabolic steroids, cardiovascular problem, social deviation

Abstract

Inconspicuous epidemic of anabolic steroids application among young recreational athletes contributes to a greater potential damaging of the overall cardiovascular and mental state of obsessed individuals. All of them turn to anabolic steroids without a rational concept and take them in big amounts with unbelievable irrational combinations (stacking) of anabolic steroids of wide spectrum and questionable quality from black market with the aim to satisfy their pathological obsession of subjectivity of muscle mass, strength and appearance. An examinee, 36 years old (with the height of 182 cm and the weight of 168 kg), recreational amateur power lifter comes to doctor because of the subjective hardships in the form of tiredness and occasional pain in chest area with exact location (on the level of sternum and pectoral muscles), denies retrosternal pain. Also, he reports dizziness and occasional leg pain. He suspects that he has insufficiency of artery peripheral circulation. Personally, he also names frequent insomnia, decrease of tolerance levels alongside tolerated aggressiveness and anger attacks with auto mutilation and periodical depression

 

Article visualizations:

Hit counter

DOI

References

Petersson A., Benqtsson J., Voltaire-Carlsson A., & Thiblin I. (2010). Substance abusers’ motives for using anabolic androgenic steroids. Drug Alcohol Depend (111), 170–172.

Beaver K.M., Vaughn M.G., DeLisi M., & Wright J.P. (2008). Anabolic–androgenic steroid use and involvement in violent behavior in a nationally representative sample of young adult males in the United States. Am J Public Health (98), 2185–2186.

Midgley S.J., Heather N., & Davies J.B. (2001). Levels of aggression among a group of anabolic–androgenic steroid users. Med Sci Law (41), 309–314.

Lundholm L., Frisell T., Lichtenstein P., & Langstrom N. (2015). Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10 365 general population men. Addiction (110), 100–108.

Choi P.Y., & Pope H.G. Jr. (1994). Violence toward women and illicit androgenic-anabolic steroid use. Ann Clin Psychiatry (6), 21–25.

National Institute on Drug Abuse Research Report Series: Anabolic Steroid Abuse, 2006.

Schulze, Jenny J. & et.al. (2008). Doping Test Results Dependent on Genotype of UGT2B 17, the Major Enzyme for Testosterone Glucuronidation. Journal of Clinical Endocrinology & Metabolism March 11, 2018.

King D.S., Sharp R.L., & Vukovich M.D. (1999). Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. J Am Med Assn. (281), 2020-2028.

Wilson J.D. (1988). Androgen abuse by athletes. Endocr Rev. (9), 181-191.

Yeater R., Reed C., Ullrich I. & et al. (1996). Resistance trained athletes using or not using anabolic steroids compared to runners: effects on cardio respiratory variables, body composition, plasma lipids. Br J Sports Med. (30), 11-14.

Muller R.W., & Hollmann W. (1998). Akute Lipoproteibeeinflussung durchein anaboles Steroid bei Kraftsportlern. Dtsch Z Sportmed. (39), 35-40.

Zmuda J.M., Fahrenbach M.C., Younkin B.T., & et al. (1993). The effect of testosterone aromatization on high-density lipoprotein choles-terol level and postheparin lipolytic activity. Metabolism (42), 446-450.

Ale´n M., &Suominen J. (1984). Effect of androgenic and anabolic steroids on spermatogenesis in power athletes. Int J Sports Med. (5), 189-192.

Durstine J.L., & Haskell W.L. (1994). Effects of exercise training on plasma ma lipids and lipoproteins. In: Holloszy JO, editor. Exercise and sport sciences reviews. Baltimore (MD): Williams & Wilkins, 477-522.

Applebaum-Bowden D., Haffner S.M., & Hazzard WR. (1987). The dysli- poproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipo- protein2 cholesterol. Metabolism (36), 949-952.

Taggart H.M., Applebaum B.D., Haffner S., & et al. (1982). Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis. Metabolism (31), 1147-1152.

Turillazzi, E., Perilli, G., Di Paolo, M., Neri, M., Riezzo, I. & Fineschi, V. (2011). Side effects of AAS abuse: an overview. Mini Rev. Med. Chem. (11), 374-389.

Severo, C., Ribeiro, J., Umpierre, D., Silveira, A.D., Padilha,M., De Aquino Neto, F. & Stein, R. (2012) Increased atherothrombotic markers and endothelial dysfunction in steroid users. Eur. J. Prev. Cardiol. 20 (2), 195e201.

Fernandez-Balsells, M. Murad, M. Lane, J.F. Lampropulos, F. Albuquerque, R.J. Mullan, N. Agrwal, M. Elamin, J. Gallegos-Orozco, A. Wang, P. Erwin, S. Bhasin, V. Montori (2010). Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab.95 (6), 2560-2575.

Dawson, R. (2001). Drugs in sport-the role of the physician. J. Endocrinol. 170 (1), 55-61.

Ammatuna, E., Nijziel, M. (2014). Polycythemia and renal infarction in a bodybuilder. Q. J. Med. 107, 661.

Shahsavarinia, K., Rahmani, F., Ebrahimi Bakhtavar, F., Hashemi Aghdam,Y., Balafar, M. (2014). A young man with myocardial infection due to trenbolone acetate; acase report. Emergency 2 (1), 43-45.

Hartgens, F., Kuipers, H. & et al. (2004). Effects of androgenic-anabolic steroids in athletes.Sports Med.34(8),513-54.

Evans N.A. et al. (2006). Current concepts in anabolic-androgenic steroids. Am J Sports Med. 32(2), 534-542.

Kindermann W. (2006). Cardiovascular side effects of anabolic-androgenic steroids. Herz 31(6), 566-573.

Haug, E. et al., Androgenic-Anabolic Steroids (AAS) and Violent Behaviour. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 04-200.

Laye-Gindhu, A., Schonert-Reichl, Kimberly A. (2005)."Nonsuicidal Self-Harm Among Community Adolescents: Understanding the "Whats" and "Whys" of Self-Harm". Journal of Youth and Adolescence. 34 (5), 447–457.

Klonsky, D. (2007). The functions of deliberate self-injury: A review of the evidence. Clinical Psychological Review. 27 (2), 226–239.

Muehlenkamp, J.J. (2005). Self-Injurious Behavior as a Separate Clinical Syndrome. American Journal of Orthopsychiatry. 75 (2), 324–333.

Downloads

Published

2019-03-27

Issue

Vol 5, No 7 (2019)

Section

Articles

License

Authors who publish with this journal agree to the following terms:

 

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

 

  1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

 

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).